.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Harvard Business School
Medtronic
Chubb
Baxter
Merck
Julphar
Fuji
Cantor Fitzgerald

Generated: June 26, 2017

DrugPatentWatch Database Preview

SEROQUEL Drug Profile

« Back to Dashboard

Which patents cover Seroquel, and what generic Seroquel alternatives are available?

Seroquel is a drug marketed by Astrazeneca Pharms and Astrazeneca and is included in two NDAs. There is one patent protecting this drug and seven Paragraph IV challenges.

The generic ingredient in SEROQUEL is quetiapine fumarate. There are fifty-one drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the quetiapine fumarate profile page.

Summary for Tradename: SEROQUEL

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list10
Bulk Api Vendors: see list47
Clinical Trials: see list174
Patent Applications: see list3,498
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SEROQUEL at DailyMed

Pharmacology for Tradename: SEROQUEL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca Pharms
SEROQUEL
quetiapine fumarate
TABLET;ORAL020639-001Sep 26, 1997ABRXYesYes► Subscribe► Subscribe
Astrazeneca Pharms
SEROQUEL
quetiapine fumarate
TABLET;ORAL020639-006Oct 4, 2005ABRXYesNo► Subscribe► Subscribe
Astrazeneca Pharms
SEROQUEL
quetiapine fumarate
TABLET;ORAL020639-004Dec 20, 1998DISCNYesNo► Subscribe► Subscribe
Astrazeneca
SEROQUEL XR
quetiapine fumarate
TABLET, EXTENDED RELEASE;ORAL022047-004May 17, 2007ABRXYesNo5,948,437*PED► SubscribeY► Subscribe
Astrazeneca
SEROQUEL XR
quetiapine fumarate
TABLET, EXTENDED RELEASE;ORAL022047-001May 17, 2007ABRXYesNo5,948,437*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SEROQUEL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms
SEROQUEL
quetiapine fumarate
TABLET;ORAL020639-004Dec 20, 19984,879,288*PED► Subscribe
Astrazeneca Pharms
SEROQUEL
quetiapine fumarate
TABLET;ORAL020639-005Jul 26, 20004,879,288*PED► Subscribe
Astrazeneca Pharms
SEROQUEL
quetiapine fumarate
TABLET;ORAL020639-001Sep 26, 19974,879,288*PED► Subscribe
Astrazeneca Pharms
SEROQUEL
quetiapine fumarate
TABLET;ORAL020639-002Sep 26, 19974,879,288*PED► Subscribe
Astrazeneca Pharms
SEROQUEL
quetiapine fumarate
TABLET;ORAL020639-006Oct 4, 20054,879,288*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: SEROQUEL

Drugname Dosage Strength RLD Submissiondate
quetiapine fumarateExtended-release Tablets150 mgSeroquel XR11/17/2008
quetiapine fumarateExtended-release Tablets50 mgSeroquel XR10/17/2008
quetiapine fumarateExtended-release Tablets400 mgSeroquel XR6/18/2008
quetiapine fumarateTablets200 mg and 300 mgSeroquel XR6/12/2008
quetiapine fumarateTablets50 mg, 150 mg and 400 mgSeroquel2/12/2007
quetiapine fumarateTablets100 mg, 200 mg and 300 mgSeroquel2/21/2006
quetiapine fumarateTablets25 mgSeroquel8/12/2005
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Farmers Insurance
AstraZeneca
Citi
Medtronic
Boehringer Ingelheim
Argus Health
Mallinckrodt
QuintilesIMS
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot